Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dara L Aisner

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2012
Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancerAndrew J Weickhardt, Benjamin Scheier, Joseph Malachy Burke, et al.
Cancer|September 12, 2013
Native and rearranged ALK copy number and rearranged cell count in non-small cell lung cancer: implications for ALK inhibitor therapyD Ross Camidge, Margaret Skokan, Porntip Kiatsimkul, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 6, 2016
Identifying the Appropriate FISH Criteria for Defining MET Copy Number-Driven Lung Adenocarcinoma through Oncogene Overlap AnalysisSinéad A Noonan, Lynne Berry, Xian Lu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 27, 2026
Recommended Terms and Definitions From the 2025 NCCN Biomarkers Resource CommitteeMelissa Y Tjota, Jennelle C Hodge, Lawrence J Jennings, et al.
NPJ Precision Oncology|January 23, 2023
Evolution of acquired resistance in a ROS1<sup>+</sup> KRAS G12C<sup>+</sup> NSCLC through the MAPK pathwayKatherine Priest, Anh Le, Amanuail Gebregzabheir, et al.
Brain Pathology (Zurich, Switzerland)|November 19, 2013
Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of casesAndrew M Donson, Bette K Kleinschmidt-DeMasters, Dara L Aisner, et al.
Molecular Carcinogenesis|December 22, 2018
Inter- and intra-tumor heterogeneity of SMAD4 loss in head and neck squamous cell carcinomasAriel L Hernandez, Ying Wang, Hilary L Somerset, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|November 3, 2023
Prospective Clinical Prognostication of Endometrial Carcinomas Based on Next-Generation Sequencing and Immunohistochemistry-Real-World Implementation and Results at a Tertiary Care CenterKurtis D Davies, Lynelle P Smith, Amy Guimaraes-Young, et al.
Clinical Lung Cancer|October 10, 2018
Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With PonatinibTerry L Ng, Hui Yu, Derek E Smith, et al.
Molecular Cancer Research : MCR|December 4, 2013
ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular driversDara L Aisner, Teresa T Nguyen, Diego D Paskulin, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2012
Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non-small-cell lung cancerAndrew J Weickhardt, Benjamin Scheier, Joseph Malachy Burke, et al.
Cancer|September 12, 2013
Native and rearranged ALK copy number and rearranged cell count in non-small cell lung cancer: implications for ALK inhibitor therapyD Ross Camidge, Margaret Skokan, Porntip Kiatsimkul, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 6, 2016
Identifying the Appropriate FISH Criteria for Defining MET Copy Number-Driven Lung Adenocarcinoma through Oncogene Overlap AnalysisSinéad A Noonan, Lynne Berry, Xian Lu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 27, 2026
Recommended Terms and Definitions From the 2025 NCCN Biomarkers Resource CommitteeMelissa Y Tjota, Jennelle C Hodge, Lawrence J Jennings, et al.
NPJ Precision Oncology|January 23, 2023
Evolution of acquired resistance in a ROS1<sup>+</sup> KRAS G12C<sup>+</sup> NSCLC through the MAPK pathwayKatherine Priest, Anh Le, Amanuail Gebregzabheir, et al.
Brain Pathology (Zurich, Switzerland)|November 19, 2013
Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of casesAndrew M Donson, Bette K Kleinschmidt-DeMasters, Dara L Aisner, et al.
Molecular Carcinogenesis|December 22, 2018
Inter- and intra-tumor heterogeneity of SMAD4 loss in head and neck squamous cell carcinomasAriel L Hernandez, Ying Wang, Hilary L Somerset, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|November 3, 2023
Prospective Clinical Prognostication of Endometrial Carcinomas Based on Next-Generation Sequencing and Immunohistochemistry-Real-World Implementation and Results at a Tertiary Care CenterKurtis D Davies, Lynelle P Smith, Amy Guimaraes-Young, et al.
Clinical Lung Cancer|October 10, 2018
Preselection of Lung Cancer Cases Using FGFR1 mRNA and Gene Copy Number for Treatment With PonatinibTerry L Ng, Hui Yu, Derek E Smith, et al.
Molecular Cancer Research : MCR|December 4, 2013
ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular driversDara L Aisner, Teresa T Nguyen, Diego D Paskulin, et al.
Pageof 13